申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US10544133B2
公开(公告)日:2020-01-28
Compounds having the following formula:
or a stereoisomer or a pharmaceutically-acceptable salt thereof, wherein R2 is a monocyclic heteroaryl group, and R1, R3, R4, R5 and R6 are as defined herein, are useful as kinase modulators, including IRAK-4 inhibition.
具有下式的化合物
或其立体异构体或药学上可接受的盐,其中 R2 是单环杂芳基,R1、R3、R4、R5 和 R6 如本文所定义,可用作激酶调节剂,包括 IRAK-4 抑制剂。